SAN DIEGO–(BUSINESS WIRE)–Carlsmed, Inc. is announcing today that the first aprevo patient specific spinal surgery has been successfully performed. Christopher Ames, M.D., director of spinal tumor and spinal deformity surgery at UC San Francisco Medical Center, assisted by Patrick Maloney, M.D., performed this landmark surgical procedure.
SAN DIEGO–(BUSINESS WIRE)–Today, Carlsmed, Inc. announces the close of a $10M Series A financing to commercialize the aprevo family of spine deformity correction devices. The San Diego-based medical device company is focused on improving outcomes for patients with adult spinal deformity. Carlsmed has pioneered a novel digital + surgical solution to create optimized surgical plans and personalized aprevo implants to enable superior correction of the spinal deformity. This round of financing is led by U.S. Venture Partners (USVP) and includes participation from The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others.
SAN DIEGO–(BUSINESS WIRE)–Carlsmed, Inc., today announced it has been granted 510(k) clearance and Breakthrough Device Designation by the FDA for its aprevo patient specific interbody devices for the correction of adult spinal deformity. The Carlsmed aprevo device is the first implant ever to receive both Breakthrough Device Designation and 510(k) market clearance from the FDA.
Carlsmed’s CEO & Co-Founder Mike Cordonnier was selected to present at the Annual SoCalBio Conference October 21-23, 2020. The annual SoCalBio Investor & Partnering Conference has grown to become the region’s premier showcase for emerging life-science companies and digital health companies.
Please join Carlsmed’s Mike Cordonnier, CEO & Co-Founder and Sharon Shulzki, COO in Session 2 of this virtual event.
The meeting will deliver outstanding scientific research, and live and pre-recorded sessions to surgical, medical and multidisciplinary spine care professionals. Participants can engage in chats and discussions as well as view the industry product gallery.
SAN DIEGO–(BUSINESS WIRE)–Carlsmed, Inc., a San Diego-based MedTech company, today announced the close of an oversubscribed $2.5M seed round. The round was led by Cove Fund II, a prominent California Life Science and Technology fund. Participating in the round are MedTech funds Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual MedTech investors.
SAN DIEGO–(BUSINESS WIRE)–Carlsmed, Inc., a San Diego-based medical technology company, today announced the appointment of Sharon Schulzki as Chief Operating Officer (COO).
SAN DIEGO–(BUSINESS WIRE)–Carlsmed, Inc., a San Diego-based medical technology company, today announced that it has completed a merger with Seattle-based spine imaging system company Precisive Surgical to offer the industry’s first personalized surgical workflow platform.
Park City, UT
San Diego, CA
Las Vegas, NV